Evidence map›Paper›PMID 37875813›Full record

Observational studyBMC microbiology2023

Association between oral microbial dysbiosis and poor functional outcomes in stroke-associated pneumonia patients.

Yueran Ren, Jingru Liang, Xiao Li, Yiting Deng, Sanping Cheng, Qiheng Wu, Wei Song, Yan He, Jiajia Zhu, Xiaomei Zhang and 2 more

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04688138 (Predictive Value of Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04688138 unknown statusnot on this map

Predictive Value of Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke: A Multiple Center Cohort Study

TypeobservationalSponsorNanfang Hospital, Southern Medical UniversityRan2020 to 2023Enrolled600ConditionsIschemic Stroke
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Oral microbiota and central nervous system diseases: A review.Neuroprotection (Chichester, England) · 2025
    Review
  13. Article
  14. Review
  15. Review
  16. Polymicrobial infections with specificJournal of oral microbiology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Yueran Ren *Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Jingru Liang *Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Xiao Li *Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yiting DengDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Sanping ChengDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Qiheng WuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Wei SongDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Yan HeMicrobiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Jiajia ZhuDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Xiaomei ZhangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Hongwei ZhouMicrobiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China. biodegradation@gmail.com.
Jia YinDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China. yinj@smu.edu.cn.
Southern Medical University · CNNanfang Hospital · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite advances in our understanding of the critical role of the microbiota in stroke patients, the oral microbiome has rarely been reported to be associated with stroke-associated pneumonia (SAP). We sought to profile the oral microbial composition of SAP patients and to determine whether microbiome temporal instability and special taxa are associated with pneumonia progression and functional outcomes.

methodsThis is a prospective, observational, single-center cohort study that examined patients with acute ischemic stroke (AIS) who were admitted within 24 h of experiencing a stroke event. The patients were divided into three groups based on the occurrence of pneumonia and the use of mechanical ventilation: nonpneumonia group, SAP group, and ventilator-associated pneumonia (VAP) group. We collected oral swabs at different time points post-admission and analyzed the microbiota using 16 S rRNA high-throughput sequencing. The microbiota was then compared among the three groups.

resultsIn total, 104 nonpneumonia, 50 SAP and 10 VAP patients were included in the analysis. We found that SAP and VAP patients exhibited significant dynamic differences in the diversity and composition of the oral microbiota and that the magnitude of this dysbiosis and instability increased during hospitalization. Then, by controlling the potential effect of all latent confounding variables, we assessed the changes associated with pneumonia after stroke and explored patients with a lower abundance of Streptococcus were more likely to suffer from SAP. The logistic regression analysis revealed that an increase in specific taxa in the phylum Actinobacteriota was linked to a higher risk of poor outcomes. A model for SAP patients based on oral microbiota could accurately predict 30-day clinical outcomes after stroke onset.

conclusionsWe concluded that specific oral microbiota signatures could be used to predict illness development and clinical outcomes in SAP patients. We proposed the potential of the oral microbiota as a non-invasive diagnostic biomarker in the clinical management of SAP patients. CLINICAL

trial registrationNCT04688138. Registered 29/12/2020, https://clinicaltrials.gov/ct2/show/NCT04688138 .

Indexed as

Ischemic StrokePneumonia, Ventilator-AssociatedStrokeCohort StudiesDysbiosisHumansProspective StudiesBiomarkerDysbiosisOral microbiotaPrognosisStroke-associated Pneumonia

Identifiers

PMID37875813
PMCPMC10594709
OpenAlexW4387904397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.